The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study

被引:136
作者
Matsushita, Kunihiro [1 ]
Blecker, Saul [2 ]
Pazin-Filho, Antonio [3 ]
Bertoni, Alain [4 ]
Chang, Patricia P. [5 ]
Coresh, Josef [1 ]
Selvin, Elizabeth [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA
[3] Univ Sao Paulo, Med Sch Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil
[4] Wake Forest Univ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC USA
[5] Univ N Carolina, Dept Med, Div Cardiol, Chapel Hill, NC USA
关键词
IMPAIRED GLUCOSE-TOLERANCE; WHOLE-BLOOD SAMPLES; CARDIOVASCULAR-DISEASE; GLYCATED HEMOGLOBIN; GLYCEMIC CONTROL; FASTING GLUCOSE; PLASMA-GLUCOSE; OUTCOMES; HOSPITALIZATION; COMPLICATIONS;
D O I
10.2337/db10-0165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-This study sought to investigate an association of HbA1c (A1C) with incident heart failure among individuals without diabetes and compare it to fasting glucose. RESEARCH DESIGN AND METHODS-We studied 11,057 participants of the Atherosclerosis Risk in Communities (ARIC) Study without heart failure or diabetes at baseline and estimated hazard ratios of incident heart failure by categories of A1C (<5.0, 5.0-5.4 [reference], 5 5-59, and 6.0-6.4%) and fasting glucose (<90, 90-99 [reference], 100-109, and 110-125 mg/dl) using Cox proportional hazards models. RESULTS-A total of 841 cases of incident heart failure hospitalization or deaths (International Classification of Disease, 9th/10th Revision, 428/150) occurred during a median follow-up of 14.1 years (incidence rate 5.7 per 1,000 person-years). After the adjustment for covariates including fasting glucose, the hazard ratio of incident heart failure was higher in individuals with A1C 6.0-6.4% (1.40 [95% CI, 1 09-1.79]) and 5.5-6.0% (1.16 [0.98-1 37]) as compared with the reference group. Similar results were observed when adjusting for insulin level or limiting to heart failure cases without preceding coronary events or developed diabetes during follow-up. In contrast, elevated fasting glucose was not associated with heart failure after adjustment for covariates and A1C. Similar findings were observed when the top quartile (A1C, 5.7-6.4%, and fasting glucose, 108-125 mg/dl) was compared with the lowest quartile (<5 2% and <95 mg/dl, respectively). CONCLUSIONS-Elevated A1C (>= 5.5-6 0%) was associated with incident heart failure in a middle-aged population without diabetes, suggesting that chronic hyperglycemia prior to the development of diabetes contributes to development of heart failure. Diabetes 59:2020-2026, 2010
引用
收藏
页码:2020 / 2026
页数:7
相关论文
共 40 条
[2]   The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy [J].
Asbun, J ;
Villarreal, FJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) :693-700
[3]   Effects of glucose intolerance on myocardial function and collagen-linked glycation [J].
Avendano, GF ;
Agarwal, RK ;
Bashey, RI ;
Lyons, MM ;
Soni, BJ ;
Jyothirmayi, GN ;
Regan, TJ .
DIABETES, 1999, 48 (07) :1443-1447
[4]   Diabetic cardiomyopathy revisited [J].
Boudina, Sihem ;
Abel, E. Dale .
CIRCULATION, 2007, 115 (25) :3213-3223
[5]   Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga Diabetes Study [J].
Cavalot, F ;
Petrelli, A ;
Traversa, M ;
Bonomo, K ;
Fiora, E ;
Conti, M ;
Anfossi, G ;
Costa, G ;
Trovati, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :813-819
[6]   Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494
[7]   Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose - Results of the Diabetes Reduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial [J].
Dagenais, G. R. ;
Gerstein, H. C. ;
Holman, R. ;
Budaj, A. ;
Escalante, A. ;
Hedner, T. ;
Keltai, M. ;
Lonn, E. ;
McFarlane, S. ;
McQueen, M. ;
Teo, K. ;
Sheridan, P. ;
Bosch, J. ;
Pogue, J. ;
Yusuf, S. .
DIABETES CARE, 2008, 31 (05) :1007-1014
[8]   CARDIAC AND PULMONARY CAUSES OF DYSPNEA - VALIDATION OF A SCORING TEST FOR CLINICAL-EPIDEMIOLOGIC USE - THE STUDY OF MEN BORN IN 1913 [J].
ERIKSSON, H ;
CAIDAHL, K ;
LARSSON, B ;
OHLSON, LO ;
WELIN, L ;
WILHELMSEN, L ;
SVARDSUDD, K .
EUROPEAN HEART JOURNAL, 1987, 8 (09) :1007-1014
[9]   Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention [J].
Goldberg, Ronald B. ;
Temprosa, Marinella ;
Haffner, Steven ;
Orchard, Trevor J. ;
Ratner, Robert E. ;
Fowler, Sarah E. ;
Mather, Kieren ;
Marcovina, Santica ;
Saudek, Chris ;
Matulik, Margaret J. ;
Price, David .
DIABETES CARE, 2009, 32 (04) :726-732
[10]   Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals [J].
Hanefeld, M ;
Koehler, C ;
Schaper, F ;
Fuecker, K ;
Henkel, E ;
Temelkova-Kurktschiev, T .
ATHEROSCLEROSIS, 1999, 144 (01) :229-235